SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
SEC Accession No. 0001193125-15-400259
Filing Date
2015-12-10
Accepted
2015-12-10 16:46:33
Documents
1
Group Members
ABG II-WX LTDBOYU CAPITAL FUND II, L.P.CONSTANT CYPRESS LTDDR. GE LIDR. NING ZHAOG&C IV LTDG&C PARTNERSHIP L.P.HILLHOUSE CAPITAL FUND II, L.P.MR. XIAOZHONG LIUMR. ZHAOHUI ZHANGNEW WUXI LIFE SCIENCE HOLDINGS LTDNEW WUXI LIFE SCIENCE LTDPING AN LIFE INSURAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.5 TO SCHEDULE 13E-3 d86213dsc13e3a.htm SC 13E3/A 75175
  Complete submission text file 0001193125-15-400259.txt   77630
Mailing Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131
Business Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131 86-21-5046-1111
WuXi PharmaTech (Cayman) Inc. (Filed by) CIK: 0001403132 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13E3/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131
Business Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131 86-21-5046-1111
WuXi PharmaTech (Cayman) Inc. (Subject) CIK: 0001403132 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13E3/A | Act: 34 | File No.: 005-83350 | Film No.: 151281321
SIC: 2834 Pharmaceutical Preparations